Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Algernon Pharmaceuticals Inc.
C.AGN
Alternate Symbol(s):
AGNPF
Consumer Cyclical
Healthcare
Advertising Agencies
Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N...
-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:AGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(3449)
•••
Marathonrunner2
X
View Profile
View Bullboard History
Post by
Marathonrunner2
on Oct 20, 2022 3:59pm
Meow, meow, meow.....cried the dead cat :( :(
oh, by the way, the cat was bouncing as well!
(16)
•••
waves1
X
View Profile
View Bullboard History
Post by
waves1
on Oct 20, 2022 3:50pm
Significant exposure from Wonderland Miami
Expecting AGN will get significant exposure at Wonderland Miami given AGN CEO Christopher Moreau will be reviewing the positive preclinical data that is driving AGN's Phase I clinical study of DMT
...more
(21)
•••
StockHawk1
X
View Profile
View Bullboard History
Post by
StockHawk1
on Oct 20, 2022 3:19pm
AGN to present @ Wonderland Psychedelic Medicine Conference
Dr. Rick Strassman, AGN consultant and author of DMT: The Spirit Molecule will join Algernon Pharmaceuticals' (AGN.c AGNPF) CEO for a keynote address at the Wonderland Psychedelic Medicine event.&
...more
(16)
•••
waves1
X
View Profile
View Bullboard History
Post by
waves1
on Oct 19, 2022 2:36pm
AGN is the leading sponsor Wonderland
AGN is trading green again today - I'm hopeful that AGN being the leading sponsor for Wonderland, the world's leading psychedelic event, will draw additional eyes and investors Algernon is
...more
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Comment by
nodaytrader
on Oct 19, 2022 11:28am
RE:DEAD cat bounce here for sure with AGN...watch out!!
Rubbish!
(15)
•••
Nice1Bucko
X
View Profile
View Bullboard History
Post by
Nice1Bucko
on Oct 19, 2022 10:33am
Algernon Pharmaceuticals AGN.c AGN AGNPF
Algernon Pharmaceuticals is the head sponsor at Wonderland, "The world's leading psychedelic event" https://www.paidpromotionalmessages.com/companies/news
...more
(3449)
•••
Marathonrunner2
X
View Profile
View Bullboard History
Post by
Marathonrunner2
on Oct 18, 2022 2:24pm
DEAD cat bounce here for sure with AGN...watch out!!
Meow meow meow....the cat will be crying much sooner than later!!
(16)
•••
waves1
X
View Profile
View Bullboard History
Post by
waves1
on Oct 18, 2022 2:05pm
AGN bounces back after yesterdays big load opportunity
What an opportunity yesterday's dip was - AGN has bounced back already! As $AGN heads into phase I DMT trials in Q4 2022 with orphan drug designation for IPF pending & 2 additional trials
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Oct 17, 2022 8:31pm
RE:AGN at 33% discount
33% of zero is just zero! Look at how much management owns versus how much they pat themselves! Look at all the warrants, look at no patents of significance. I wouldn't recommend this to my worst
...more
(21)
•••
StockHawk1
X
View Profile
View Bullboard History
Post by
StockHawk1
on Oct 17, 2022 5:49pm
AGN at 33% discount
Algernon Pharmaceuticals/AGN.c is looking very undervalued rn after dropping 33.5% today seemingly out of the blue. The dip was pretty surprising but IMO presents a very good opportunity to
...more
(15)
•••
Nice1Bucko
X
View Profile
View Bullboard History
Post by
Nice1Bucko
on Oct 17, 2022 2:41pm
👀👀 💊💊💊👨🏻⚕️👨🏻⚕️ AGN.c AGN AGNPF
Algernon Pharmaceuticals are introducing DMT for stroke treatment and Ifenprodil for chronic cough / respiratory disease
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Oct 15, 2022 5:39pm
RE:👀👀🙏🏼🙏🏼 Algernon Pharmaceuticals
Paying shareholders money to sponsor an event then posting a paid content posting to promote it, no wonder this thing is a nightmare
(15)
•••
Nice1Bucko
X
View Profile
View Bullboard History
Post by
Nice1Bucko
on Oct 14, 2022 5:44pm
👀👀🙏🏼🙏🏼 Algernon Pharmaceuticals
Dr Rick Strassman joining CEO Christopher Moreau for Wonderland keynote address AGN.c AGN AGNPF https://www.paidpromotionalmessages.com/companies/news/995428/algernon
...more
(21)
•••
StockHawk1
X
View Profile
View Bullboard History
Post by
StockHawk1
on Oct 14, 2022 2:47pm
AGN keynote presentation at Wonderland
Today, Algernon Pharmaceuticals Inc. (AGN.c AGNPF) announced that Dr. Rick Strassman, AGN consultant and author of DMT: The Spirit Molecule will join AGN's CEO for a keynote address at Wonderland.
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 14, 2022 7:00am
New Press Release - Algernon Pharmaceuticals Announces Dr. Rick Strassman author of "DMT: The Spirit Molecule" to Join CEO Christopher J. Moreau for Keynote Science Address at Wonderland Conference
VANCOUVER, British Columbia, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage Canadian pharmaceutical development company, is pleased to announce that Dr. Rick Strassman, author of the book...
read article.
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Nanalysis Announces Third Quarter 2024 Conference Call
GameSquare to Report Q3 2024 Financial Results on November 14, 2024
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
Learn About a Mining Portfolio of More Than 250 Projects and Royalties Across North America
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.